论文部分内容阅读
目的:探讨胸肺部物理疗法在重症监护病房(ICU)患者排痰中的应用效果。方法:选取2015年7月~2016年7月我院ICU收治的76例患者作为研究对象,将患者随机等分为物理组和传统组,物理组患者排痰采用胸肺部物理疗法,传统组患者排痰采用传统排痰方法,比较两组患者的排痰量、痰液黏稠度、血氧饱和度(SpO_2),二氧化碳分压(PaCO_2)、氧分压(PaO_2)、氧分压/吸氧浓度比值(PaO_2/FiO_2)及排痰治疗效果等各项指标,并比较分析两种方法结果之间的差异性。结果:物理组患者的排痰量多于传统组(P<0.05),排出痰液黏稠度低于传统组(P<0.05),排痰后动脉血中SpO_2、PaO_2和PO2/FiO_2比值均高于传统组(P<0.05),PaCO_2低于传统组(P<0.05),物理组的排痰疗效高于传统组(P<0.05)。结论:胸肺部物理疗法对ICU患者排痰的效果更好,能改善患者的换气及通气功能,以能提高患者排痰治疗效果,对预防ICU患者继发性肺部感染具有重要意义。
Objective: To explore the effect of physiotherapy of thorax and lung in expectoration of patients in intensive care unit (ICU). Methods: From July 2015 to July 2016, 76 patients admitted to our hospital were enrolled in this study. The patients were randomly divided into two groups: physical group and traditional group. Physiotherapy group was performed with thoracic and lung physical therapy, conventional group In patients with sputum aspiration, traditional sputum aspiration method was used to compare sputum output, sputum viscosity, blood oxygen saturation (SpO_2), partial pressure of carbon dioxide (PaCO_2), partial pressure of oxygen (PaO_2) Oxygen concentration ratio (PaO 2 / FiO 2) and expectoration efficacy and other indicators, and comparative analysis of the differences between the results of two methods. Results: Compared with the traditional group (P <0.05), the sputum viscosity of the discharged sputum was lower in the physical group than in the traditional group (P <0.05), and the values of SpO_2, PaO_2 and PO2 / FiO_2 were significantly higher in the sputum In the traditional group (P <0.05), PaCO_2 was lower than that in the traditional group (P <0.05), and the curative effect of phlegm in the physical group was higher than that in the traditional group (P <0.05). Conclusion: Physiotherapy of thoracic and pulmonary tuberculosis is more effective in expelling sputum in patients with ICU. It can improve ventilation and ventilation in patients with ICU, which can improve the efficacy of sputum aspiration therapy in patients with ICU. It is of great significance to prevent secondary pulmonary infection in ICU patients.